Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctioncoumarin 7-hydroxylase activity

CYP2A6 CYP2A7 CYP2A13

5.75e-0731673GO:0008389
GeneOntologyMolecularFunctioninhibitory MHC class I receptor activity

LILRA2 LILRB1 LILRA5 LILRB4

2.22e-06121674GO:0032396
GeneOntologyMolecularFunctionMHC class I receptor activity

LILRA2 LILRB1 LILRA5 LILRB4

1.32e-05181674GO:0032393
GeneOntologyBiologicalProcesscellular response to xenobiotic stimulus

CYP2A6 CYP2A7 CYP2A13 CAD SLCO2B1 RECQL5 UMPS IL1B SUFU NR1H4

1.38e-0522216710GO:0071466
GeneOntologyBiologicalProcessresponse to xenobiotic stimulus

CYP2A6 CYP2A7 CYP2A13 ABCA3 CAD SLCO2B1 SLC10A4 CROT RECQL5 UMPS LTA ATP1A1 IL1B SUFU NR1H4

2.52e-0552516715GO:0009410
GeneOntologyBiologicalProcessphenylpropanoid metabolic process

CYP2A6 CYP2A7 CYP2A13

6.00e-05101673GO:0009698
GeneOntologyBiologicalProcesscoumarin metabolic process

CYP2A6 CYP2A7 CYP2A13

6.00e-05101673GO:0009804
GeneOntologyBiologicalProcessregulation of immune response

TRPM4 SPHK2 LILRA2 CARMIL2 GPR32 GPR32P1 NSD2 NLRP1 LILRB1 MAP3K1 DDX3X EPG5 KIR2DL5B FCRLB KIR2DL5A CARD11 LTA IL1B LILRA5 NR1H4 IFNL3 LILRB4

6.70e-05108516722GO:0050776
DomainCyt_P450_E_grp-I_CYP2A-like

CYP2A6 CYP2A7 CYP2A13

2.64e-0641643IPR008067
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

DOC2A SEMA6B TRPM4 FLNA SPHK2 EPPK1 SZT2 NSD2 KSR2 OBSCN DCTN1 BIRC6 ARHGEF10L HIVEP3 ARHGEF40 SCAP ARAP3 MDN1 MEGF8 SH3TC1 NEK8 CSPG4 ZFYVE26 WDFY3 ESPL1 SUFU TNPO3 PLK3 MED12

2.06e-1311051722935748872
Pubmed

Alternative mRNA splicing creates transcripts encoding soluble proteins from most LILR genes.

LILRA2 LILRB1 LILRA5 LILRB4

2.00e-087172419658091
Pubmed

The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.

FLNA CAD ANKFY1 ACTN1 ECPAS DCTN1 DDX3X SF3B1 MDN1 SEC23IP DKC1 NOC4L UMPS ATP1A1 ZW10 DDX41 TNPO3

2.20e-086381721733239621
Pubmed

Regulation of bile acid metabolism in mouse models with hydrophobic bile acid composition.

CYP2A6 CYP2A7 CYP2A13

1.19e-073172331645370
Pubmed

A trans-acting locus regulates transcriptional repression of the female-specific steroid 15 alpha-hydroxylase gene in male mice.

CYP2A6 CYP2A7 CYP2A13

1.19e-07317238297477
Pubmed

Lack of the steroid 15 alpha-hydroxylase gene (Cyp2a-4) in wild mouse strain Mus spretus: rapid evolution of the P450 gene superfamily.

CYP2A6 CYP2A7 CYP2A13

1.19e-07317238188299
Pubmed

Comparison of hamster and mouse reveals interspecies differences in the regulation of hepatic CYP2A isozymes.

CYP2A6 CYP2A7 CYP2A13

1.19e-07317238250953
Pubmed

The structure and characterization of type I P-450(15) alpha gene as major steroid 15 alpha-hydroxylase and its comparison with type II P-450(15) alpha gene.

CYP2A6 CYP2A7 CYP2A13

1.19e-07317232703500
Pubmed

Alteration of the substrate specificity of mouse 2A P450s by the identity of residue-209: steroid-binding site and orientation.

CYP2A6 CYP2A7 CYP2A13

1.19e-073172322217847
Pubmed

Differential distribution of CYP2A6 and CYP2A13 in the human respiratory tract.

CYP2A6 CYP2A7 CYP2A13

1.19e-073172322890016
Pubmed

Reciprocal regulation of sex-dependent expression of testosterone 15 alpha-hydroxylase (P-450(15 alpha)) in liver and kidney of male mice by androgen. Evidence for a single gene.

CYP2A6 CYP2A7 CYP2A13

1.19e-07317233346244
Pubmed

Alteration of mouse cytochrome P450coh substrate specificity by mutation of a single amino-acid residue.

CYP2A6 CYP2A7 CYP2A13

1.19e-07317232733794
Pubmed

Site-directed mutagenesis of mouse steroid 7 alpha-hydroxylase (cytochrome P-450(7) alpha): role of residue-209 in determining steroid-cytochrome P-450 interaction.

CYP2A6 CYP2A7 CYP2A13

1.19e-07317238484736
Pubmed

Cerium-induced strain-dependent increase in Cyp2a-4/5 (cytochrome P4502a-4/5) expression in the liver and kidneys of inbred mice.

CYP2A6 CYP2A7 CYP2A13

1.19e-07317231417950
Pubmed

Impact of nicotine metabolism on nicotine's pharmacological effects and behavioral responses: insights from a Cyp2a(4/5)bgs-null mouse.

CYP2A6 CYP2A7 CYP2A13

1.19e-073172324045421
Pubmed

Highly homologous mouse Cyp2a4 and Cyp2a5 genes are differentially expressed in the liver and both express long non-coding antisense RNAs.

CYP2A6 CYP2A7 CYP2A13

1.19e-073172332987105
Pubmed

Mouse steroid 15 alpha-hydroxylase gene family: identification of type II P-450(15)alpha as coumarin 7-hydroxylase.

CYP2A6 CYP2A7 CYP2A13

1.19e-07317232765478
Pubmed

Sexual dimorphism of testosterone 15 alpha-hydroxylase mRNA levels in mouse liver. cDNA cloning and regulation.

CYP2A6 CYP2A7 CYP2A13

1.19e-07317232415518
Pubmed

Circadian expression of the steroid 15 alpha-hydroxylase (Cyp2a4) and coumarin 7-hydroxylase (Cyp2a5) genes in mouse liver is regulated by the PAR leucine zipper transcription factor DBP.

CYP2A6 CYP2A7 CYP2A13

4.74e-074172310490589
Pubmed

Two steroid 15 alpha-hydroxylase genes and a homologous gene family in mice.

CYP2A6 CYP2A7 CYP2A13

4.74e-07417231970547
Pubmed

Transcriptional regulation by HNF-4 of the steroid 15alpha-hydroxylase P450 (Cyp2a-4) gene in mouse liver.

CYP2A6 CYP2A7 CYP2A13

4.74e-07417239408084
Pubmed

A DNA methylation site in the male-specific P450 (Cyp 2d-9) promoter and binding of the heteromeric transcription factor GABP.

CYP2A6 CYP2A7 CYP2A13

4.74e-07417237565685
Pubmed

A synthetic interaction screen identifies factors selectively required for proliferation and TERT transcription in p53-deficient human cancer cells.

ELL3 EPG5 RPUSD4 RECQL5 HINT3 UMPS NEUROG2

9.69e-07105172723284306
Pubmed

LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.

FLNA PDE3B ERC1 DCAF16 ECPAS THEM6 FOXRED2 ARHGEF40 SCAP SEC23IP UMPS CHPF2 ATP1A1 ZW10 ESPL1 TNPO3 YIPF3 SLC27A3

1.13e-069421721831073040
Pubmed

A High-Density Human Mitochondrial Proximity Interaction Network.

MRM2 PDE3B CAD VPS13C RNF213 MRPS16 MRPL28 BIRC6 THEM6 RPUSD4 MDN1 WDR6 NUP37 SEC23IP DKC1 MRPS5 NOC4L PLD6 ATP1A1 ZW10 DDX41 ESPL1 GNL1

1.47e-0614961722332877691
Pubmed

Defining the membrane proteome of NK cells.

FLNA PDE3B CAD CARMIL2 CNOT10 RNF213 TYSND1 ECPAS DCTN1 BIRC6 MDN1 IQSEC1 DDX3Y CHPF2 ADGRE5 ZW10 DDX41 ALG12 MED12 SLC27A3

1.51e-0611681722019946888
Pubmed

A genetic polymorphism in coumarin 7-hydroxylation: sequence of the human CYP2A genes and identification of variant CYP2A6 alleles.

CYP2A6 CYP2A7 CYP2A13

2.35e-06617237668294
Pubmed

Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells: structural evidence for new stimulatory and inhibitory pathways.

LILRA2 LILRB1 LILRB4

2.35e-06617239079806
Pubmed

Organization and evolution of the cytochrome P450 CYP2A-2B-2F subfamily gene cluster on human chromosome 19.

CYP2A6 CYP2A7 CYP2A13

2.35e-06617238587134
Pubmed

Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.

FLNA CAD ANKFY1 DSC3 KIF21A WDR46 ACTN1 DCTN1 BIRC6 ARHGEF40 SF3B1 ARAP3 MDN1 WDR6 RECQL5 IQSEC1 DKC1 WDFY3 DDX41 MED12 PARP12

3.78e-0613531722129467282
Pubmed

Differential expression of leukocyte immunoglobulin-like receptors on cord-blood-derived human mast cell progenitors and mature mast cells.

LILRA2 LILRB1 LILRB4

4.10e-067172317998301
Pubmed

Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses.

CYP2A6 CYP2A7 CYP2A13

4.10e-06717239630227
Pubmed

Organization and evolution of the Cyp2 gene cluster on mouse chromosome 7, and comparison with the syntenic human cluster.

CYP2A6 CYP2A7 CYP2A13

4.10e-067172314630516
Pubmed

Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

FLNA CAD EPPK1 NSD2 WDR46 ACTN1 ECPAS BIRC6 SF3B1 MDN1 WDR6 NOC4L ATP1A1 MED12

5.13e-066531721422586326
Pubmed

A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules.

LILRA2 LILRB1 LILRB4

6.54e-06817239548455
Pubmed

Genes encoding alpha and beta subunits of Na,K-ATPase are located on three different chromosomes in the mouse.

CYP2A6 CYP2A13 ATP1A1

6.54e-06817232885848
Pubmed

PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation.

FLNA CAD ANKFY1 CNOT10 MRPS16 DDX3X ZCCHC4 SF3B1 WDR6 IQSEC1 DKC1 MRPS5 NOC4L DDX41

7.84e-066781721430209976
Pubmed

Identification of different proteins binding to Na, K-ATPase α1 in LPS-induced ARDS cell model by proteomic analysis.

FLNA CAD WDR46 RNF213 DDX3X SF3B1 ATP1A1

7.96e-06144172735681168
Pubmed

RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.

CAD WDR4 DCTN1 DDX3X ARHGEF40 SF3B1 ATP1A1 DMPK

8.05e-06202172824639526
Pubmed

Maternal DHA intake in mice increased DHA metabolites in the pup brain and ameliorated MeHg-induced behavioral disorder.

CYP2A6 CYP2A7 CYP2A13

9.77e-069172337838304
Pubmed

Inhibitory immunoglobulin-like receptors LILRB and PIR-B negatively regulate osteoclast development.

LILRA2 LILRB1 LILRB4

1.39e-0510172318802077
Pubmed

Mitotic control of kinetochore-associated dynein and spindle orientation by human Spindly.

DCTN1 BUB1B ZW10

1.39e-0510172319468067
Pubmed

USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.

FLNA CAD DDX3X FAT2 SF3B1 MDN1 UMPS TNPO3

2.33e-05234172836243803
Pubmed

Characterization of a novel CYP2A7/CYP2A6 hybrid allele (CYP2A6*12) that causes reduced CYP2A6 activity.

CYP2A6 CYP2A7

2.43e-052172212325023
Pubmed

Suppressed hepatocyte proliferation via a ROS-HNE-P21 pathway is associated with nicotine- and cotinine-enhanced alcoholic fatty liver in mice.

CYP2A6 CYP2A13

2.43e-052172230876690
Pubmed

CYP2A5 induction and hepatocellular stress: an adaptive response to perturbations of heme homeostasis.

CYP2A6 CYP2A13

2.43e-052172221395539
Pubmed

Some human KIR haplotypes contain two KIR2DL5 genes: KIR2DL5A and KIR2DL5B.

KIR2DL5B KIR2DL5A

2.43e-052172212185535
Pubmed

Nuclear localization and mitogen-activated protein kinase phosphorylation of the multifunctional protein CAD.

CAD UMPS

2.43e-052172215890648
Pubmed

Species differences in coumarin metabolism: a molecular modelling evaluation of CYP2A interactions.

CYP2A6 CYP2A13

2.43e-052172212162851
Pubmed

Molecular characterization of the murine Coh locus: an amino acid difference at position 117 confers high and low coumarin 7-hydroxylase activity in P450coh.

CYP2A6 CYP2A13

2.43e-05217221302041
Pubmed

Structural alteration of mouse P450coh by mutation of glycine-207 to proline: spin equilibrium, enzyme kinetics, and heat sensitivity.

CYP2A6 CYP2A13

2.43e-05217228395817
Pubmed

Absence of cytochrome P450 2A5 enhances alcohol-induced liver injury in mice.

CYP2A6 CYP2A13

2.43e-052172225804444
Pubmed

Gene structure and promoter variation of expressed and nonexpressed variants of the KIR2DL5 gene.

KIR2DL5B KIR2DL5A

2.43e-052172211086080
Pubmed

Effect of pyrazole, cobalt and phenobarbital on mouse liver cytochrome P-450 2a-4/5 (Cyp2a-4/5) expression.

CYP2A6 CYP2A13

2.43e-05217221520280
Pubmed

Role of CYP2A13 in the bioactivation and lung tumorigenicity of the tobacco-specific lung procarcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone: in vivo studies using a CYP2A13-humanized mouse model.

CYP2A6 CYP2A13

2.43e-052172223917075
Pubmed

Splicing factor SF3B1 promotes endometrial cancer progression via regulating KSR2 RNA maturation.

KSR2 SF3B1

2.43e-052172233040078
Pubmed

CYP2A7 polymorphic alleles confound the genotyping of CYP2A6*4A allele.

CYP2A6 CYP2A7

2.43e-052172216636685
Pubmed

Genomic Landscape of Experimental Bladder Cancer in Rodents and Its Application to Human Bladder Cancer: Gene Amplification and Potential Overexpression of Cyp2a5/CYP2A6 Are Associated with the Invasive Phenotype.

CYP2A6 CYP2A13

2.43e-052172227902773
Pubmed

Genetic polymorphisms of inflammasome genes associated with pediatric acute lymphoblastic leukemia and clinical prognosis in the Brazilian Amazon.

NLRP1 IL1B

2.43e-052172233972620
Pubmed

Circadian Regulation of Hepatic Cytochrome P450 2a5 by Peroxisome Proliferator-Activated Receptor γ.

CYP2A6 CYP2A13

2.43e-052172230154104
Pubmed

Expression of CYP2A genes in human liver and extrahepatic tissues.

CYP2A7 CYP2A13

2.43e-052172210353262
Pubmed

Mechanism-based inhibition of cytochrome P450 (CYP)2A6 by chalepensin in recombinant systems, in human liver microsomes and in mice in vivo.

CYP2A6 CYP2A13

2.43e-052172221418183
Pubmed

IL-1β (-511T/C) gene polymorphism not IL-1β (+3953T/C) and LT-α (+252A/G) gene variants confers susceptibility to visceral leishmaniasis.

LTA IL1B

2.43e-052172222311026
Pubmed

Association of KIR2DL5B gene with celiac disease supports the susceptibility locus on 19q13.4.

KIR2DL5B KIR2DL5A

2.43e-052172217215859
Pubmed

Role of CYP2A5 in the clearance of nicotine and cotinine: insights from studies on a Cyp2a5-null mouse model.

CYP2A6 CYP2A13

2.43e-052172219923441
Pubmed

Effects of lipopolysaccharide-stimulated inflammation and pyrazole-mediated hepatocellular injury on mouse hepatic Cyp2a5 expression.

CYP2A6 CYP2A13

2.43e-052172212499123
Pubmed

Polymorphisms of interleukin-1 beta and beta 3-adrenergic receptor in Japanese patients with nonalcoholic steatohepatitis.

ADRB3 IL1B

2.43e-052172215318095
Pubmed

Function and regulation of the Cyp2a5/CYP2A6 genes in response to toxic insults in the liver.

CYP2A6 CYP2A13

2.43e-052172222497566
Pubmed

ASB2α, an E3 ubiquitin ligase specificity subunit, regulates cell spreading and triggers proteasomal degradation of filamins by targeting the filamin calponin homology 1 domain.

FLNA ASB2

2.43e-052172224052262
Pubmed

Plasmacytoid dendritic cells in patients with autoimmune thyroid disease.

LILRB1 LILRB4

2.43e-052172223666960
Pubmed

LIR9, an immunoglobulin-superfamily-activating receptor, is expressed as a transmembrane and as a secreted molecule.

LILRA2 LILRA5

2.43e-052172212393390
Pubmed

The role of CYP2A5 in liver injury and fibrosis: chemical-specific difference.

CYP2A6 CYP2A13

2.43e-052172226363552
Pubmed

Mouse liver P450Coh: genetic regulation of the pyrazole-inducible enzyme and comparison with other P450 isoenzymes.

CYP2A6 CYP2A13

2.43e-05217222712571
Pubmed

Structural characterization and expression studies of Dby and its homologs in the mouse.

DDX3X DDX3Y

2.43e-052172216728723
Pubmed

Evaluation of inhibition selectivity for human cytochrome P450 2A enzymes.

CYP2A6 CYP2A13

2.43e-052172222696418
Pubmed

Leukocyte immunoglobulin-like receptor B1 and B4 (LILRB1 and LILRB4): Highly sensitive and specific markers of acute myeloid leukemia with monocytic differentiation.

LILRB1 LILRB4

2.43e-052172232918786
Pubmed

Nicotine enhances alcoholic fatty liver in mice: Role of CYP2A5.

CYP2A6 CYP2A13

2.43e-052172230222954
Pubmed

Up-regulation of CYP2A5 expression by porphyrinogenic agents in mouse liver.

CYP2A6 CYP2A13

2.43e-05217227543189
Pubmed

Sexually dimorphic RNA helicases DDX3X and DDX3Y differentially regulate RNA metabolism through phase separation.

DDX3X DDX3Y

2.43e-052172235588748
Pubmed

Characterization and regulation of sex-specific mouse steroid hydroxylase genes.

CYP2A6 CYP2A13

2.43e-05217222372744
Pubmed

The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes.

CYP2A6 CYP2A7

2.43e-05217222322567
Pubmed

Metabolic effects of CYP2A6 and CYP2A13 on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced gene mutation--a mammalian cell-based mutagenesis approach.

CYP2A6 CYP2A13

2.43e-052172221473878
Pubmed

Gene structure of the human DDX3 and chromosome mapping of its related sequences.

DDX3X DDX3Y

2.43e-052172211710523
Pubmed

The CYP2A gene subfamily: species differences, regulation, catalytic activities and role in chemical carcinogenesis.

CYP2A6 CYP2A13

2.43e-05217227581481
Pubmed

Expression and alternative splicing of the cytochrome P-450 CYP2A7.

CYP2A6 CYP2A7

2.43e-05217227864805
Pubmed

Interstrain differences in the expression and activity of Cyp2a5 in the mouse liver.

CYP2A6 CYP2A13

2.43e-052172228298240
Pubmed

Genetic polymorphisms for a phenobarbital-inducible cytochrome P-450 map to the Coh locus in mice.

CYP2A6 CYP2A13

2.43e-05217226309775
Pubmed

Sequential inverse dysregulation of the RNA helicases DDX3X and DDX3Y facilitates MYC-driven lymphomagenesis.

DDX3X DDX3Y

2.43e-052172234437837
Pubmed

Characterization of D1Pas1, a mouse autosomal homologue of the human AZFa region DBY, as a nuclear protein in spermatogenic cells.

DDX3X DDX3Y

2.43e-052172211591417
Pubmed

Role of CYP2A5 in the bioactivation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mice.

CYP2A6 CYP2A13

2.43e-052172222262919
Pubmed

Modulation of cytochrome P450 2A5 activity by lipopolysaccharide: low-dose effects and non-monotonic dose-response relationship.

CYP2A6 CYP2A13

2.43e-052172225635819
Pubmed

Genetic variation between mice in their metabolism of coumarin and its derivatives.

CYP2A6 CYP2A13

2.43e-0521722566237
Pubmed

An azoospermic factor gene, Ddx3y and its paralog, Ddx3x are dispensable in germ cells for male fertility.

DDX3X DDX3Y

2.43e-052172230613052
Pubmed

Identification and characterization of a 44 kDa protein that binds specifically to the 3'-untranslated region of CYP2a5 mRNA: inducibility, subcellular distribution and possible role in mRNA stabilization.

CYP2A6 CYP2A13

2.43e-05217228611142
Pubmed

The E3 ubiquitin ligase specificity subunit ASB2α targets filamins for proteasomal degradation by interacting with the filamin actin-binding domain.

FLNA ASB2

2.43e-052172221750192
Pubmed

Coumarin toxicity in different strains of mice.

CYP2A6 CYP2A13

2.43e-0521722665441
Pubmed

Essential role of the cytochrome P450 enzyme CYP2A5 in olfactory mucosal toxicity of naphthalene.

CYP2A6 CYP2A13

2.43e-052172224104196
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

TRIM46 CAD ANKFY1 ERC1 KIF21A KSR2 DCTN1 DDX3X SF3B1 MDN1 SEC23IP IQSEC1 FBXO41 MTCL1 WDFY3 MAPK8IP2

2.57e-059631721628671696
Pubmed

Genotype frequencies of 50 polymorphisms for 241 Japanese non-cancer patients.

CYP2A6 ADRB3 LTA IL1B

3.01e-0536172412164325
Pubmed

The ubiquitin-specific protease USP36 SUMOylates EXOSC10 and promotes the nucleolar RNA exosome function in rRNA processing.

FLNA CAD ANKFY1 WDR46 DDX3X WDR6 DKC1 MRPS5 NOC4L ATP1A1 DDX41

3.14e-054831721136912080
InteractionTOP3B interactions

DOC2A SEMA6B TRPM4 FLNA SPHK2 CAD EPPK1 SZT2 NSD2 CNOT10 KSR2 OBSCN ACTN1 DCTN1 BIRC6 DDX3X ARHGEF10L FBXL6 HIVEP3 ARHGEF40 SCAP ARAP3 MDN1 MEGF8 SH3TC1 NEK8 CSPG4 RECQL5 DKC1 ZFYVE26 WDFY3 ESPL1 SUFU TNPO3 PLK3 MED12

1.07e-09147016136int:TOP3B
InteractionCYP2A7 interactions

CYP2A6 CYP2A7 CYP2A13

5.00e-0731613int:CYP2A7
CytobandEnsembl 112 genes in cytogenetic band chr19q13

TRPM4 CYP2A6 CYP2A7 NLRP12 SPHK2 CYP2A13 LILRA2 GPR32 GPR32P1 APLP1 LILRB1 MEGF8 DMPK LILRA5 IFNL3 LILRB4 FAM98C

2.85e-06119217217chr19q13
Cytoband7p22

MRM2 ANKRD61 CARD11

5.62e-052017237p22
Cytoband19q13.4

LILRA2 LILRB1 LILRA5 LILRB4

2.30e-0479172419q13.4
Cytoband16p13.3

ABCA3 MRPL28 PRR25 IGFALS ANTKMT TPSG1

3.35e-04244172616p13.3
Cytoband19q13.2

CYP2A6 CYP2A7 SPHK2 CYP2A13 FAM98C

4.01e-04164172519q13.2
GeneFamilyCD molecules|Inhibitory leukocyte immunoglobulin like receptors

LILRB1 LILRB4

4.03e-04511621182
GeneFamilyCD molecules|Activating leukocyte immunoglobulin like receptors

LILRA2 LILRA5

6.02e-04611621181
GeneFamilyZinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors

ANKFY1 ZFYVE26 WDFY3

1.01e-0331116381
GeneFamilyCytochrome P450 family 2

CYP2A6 CYP2A7 CYP2A13

1.45e-033511631001
GeneFamilyWD repeat domain containing

WDR4 KIF21A WDR46 SCAP WDR6 NUP37 WDFY3

1.51e-032621167362
GeneFamilyDEAD-box helicases

DDX3X DDX3Y DDX41

2.46e-03421163499
CoexpressionPRC2_EED_DN.V1_DN

TRIM46 TRPM4 CAD DUSP7 APLP1 MAP3K6 FBXL6 HIVEP3 CSPG4 BUB1B ALG12

5.12e-0819316811M2734
CoexpressionNAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN

SEMA6B CYP2A6 CYP2A7 HK3 GPR32 FBXL8 NSD2 ERC1 OBSCN DGKG NLRP1 APLP1 IGFALS MEGF8 BUB1B KIR2DL5A CHPF2 WDFY3 IL1B NEUROG2

1.65e-0690916820M41018
ToppCell5'-Adult-SmallIntestine-Hematopoietic-Myeloid-Monocytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SEMA6B FLNA NLRP12 LILRA2 HK3 LILRB1 IL1B LILRA5 LILRB4

4.96e-081891709984b5f21e84dd8273d8437ac2a5a9de4e9484b9a
ToppCell10x5'-lymph-node_spleen-Myeloid_Monocytic|lymph-node_spleen / Manually curated celltypes from each tissue

SEMA6B NLRP12 LILRA2 HK3 LILRB1 WDFY3 IL1B LILRA5 LILRB4

7.38e-0819817092541f1095ed91e6789cb888cf39a208b8107726a
ToppCellParenchymal-10x5prime-Immune_Myeloid-Monocytic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

NLRP12 LILRA2 HK3 LILRB1 MAP3K1 HES4 IL1B LILRA5 LILRB4

8.05e-0820017090855ebb10b925664aa5cf813d97e97683c46180d
ToppCell3'-GW_trimst-2-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TRIM46 CARMIL2 KIF21A SLC10A4 APLP1 TAS1R1 LRRN2 MAPK8IP2

3.99e-071761708bfea433544c6d6b8ad55e50ca94c5574460c2e0b
ToppCell3'-GW_trimst-2-LargeIntestine-Neuronal-neurons_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TRIM46 CARMIL2 KIF21A SLC10A4 APLP1 TAS1R1 LRRN2 MAPK8IP2

3.99e-0717617083c78dee7e1111a579fde6d401b9ecb4d5b8e782f
ToppCell10x5'-lymph-node_spleen-Myeloid_Mac-Cycling_Myeloid-Mac|lymph-node_spleen / Manually curated celltypes from each tissue

DIPK1C HK3 SLCO2B1 ARHGEF10L BUB1B WDFY3 ESPL1 LILRB4

4.74e-0718017084eea8366cdb82c356325ce88f09ad8b302c17a07
ToppCell5'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SEMA6B FLNA NLRP12 LILRB1 DDX3X FSCN2 IL1B LILRA5

5.15e-071821708c3eafdc11858566aa7692b2f5dbe72ac01fb769a
ToppCell3'_v3-GI_small-bowel-Myeloid_Monocytic-Nonclassical_monocytes|GI_small-bowel / Manually curated celltypes from each tissue

LILRA2 HK3 LILRB1 ARHGEF10L IL1B NEUROG2 LILRA5 LILRB4

6.32e-071871708c20689022569640ebc4a878e3fe146b86fe9b386
ToppCell3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

FLNA HK3 SLCO2B1 LILRB1 ARHGEF10L IQSEC1 ZFYVE26 LILRB4

8.02e-071931708222829c30ebe47f0ed1e035897e3cd4be10b2a11
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

NLRP12 LILRA2 HK3 LILRB1 ADGRE5 IL1B LILRA5 LILRB4

8.67e-07195170810ce1b6961f10372d1f65388cbf3626a5fcd6840
ToppCellLPS_only-Myeloid-Dendritic_cells-pDC|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SLC2A9 DSC3 NLRP1 APLP1 ELL3 ADRB3 CARD11

8.96e-0713517070afe232aa1a1e6c37a5b3183b67d7fa07e0ea791
ToppCellcontrol-Myeloid-Non-resident_Macrophage|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

SEMA6B LILRA2 HK3 SLCO2B1 LILRB1 IL1B LILRA5 LILRB4

9.01e-071961708646a8d47dddffdfd2d8a62245ea6cd49f9510a1a
ToppCellNS-control-d_0-4-Myeloid-Non-resident_Macrophage|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

SEMA6B LILRA2 HK3 SLCO2B1 LILRB1 IL1B LILRA5 LILRB4

9.36e-071971708496a1115071a1be6928786192de49f3adf197dfb
ToppCellNS-moderate-d_07-13-Myeloid-Non-resident_Macrophage|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

SEMA6B FLNA SLCO2B1 ACTN1 LILRB1 IL1B LILRA5 LILRB4

9.36e-071971708774a5053f43ac7d614c127ae7363d32a3a194f63
ToppCellControl-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class

DOC2A FLNA RNF213 MEGF8 FCRLB CARD11 MDGA1 PARP12

9.72e-07198170876d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7
ToppCell10x5'-lymph-node_spleen-Myeloid_Monocytic-Classical_monocytes|lymph-node_spleen / Manually curated celltypes from each tissue

SEMA6B NLRP12 LILRA2 HK3 WDFY3 IL1B LILRA5 LILRB4

9.72e-071981708934dacb67d71faa2f8732c39d7f8e64b0ee75396
ToppCellTracheal-10x5prime-Immune_Myeloid-Macrophage_other-Macro_CCL|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

SEMA6B DIPK1C LILRA2 SLCO2B1 LILRB1 IL1B LILRA5 LILRB4

1.01e-061991708c72279fa3ca2ebc42a1446507673df154b8033c7
ToppCellmoderate-Myeloid-Non-resident_Macrophage|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

SEMA6B FLNA HK3 SLCO2B1 LILRB1 IL1B LILRA5 LILRB4

1.01e-061991708614c1e788d89310e78984241977941beed8d12dc
ToppCellParenchymal-10x5prime-Immune_Myeloid-Monocytic-Monocyte_CD16|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

LILRA2 HK3 LILRB1 MAP3K1 HES4 IL1B LILRA5 LILRB4

1.05e-06200170883d9aa5b46ae7a71a258b2e44b3251f95bc9a1b7
ToppCellBronchial-10x5prime-Immune_Myeloid-Monocytic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

NLRP12 LILRA2 HK3 LILRB1 MAP3K1 HES4 IL1B LILRA5

1.05e-062001708d237cf947d6768b022d18211e14af4adb4990708
ToppCellfacs-Liver-Non-hepatocytes-3m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TRPM4 HK3 KSR2 NLRP1 MEGF8 MDGA1 LILRA5

1.98e-061521707b61d2f6ee819c8dd4b4b601a8bc8388b1983de58
ToppCellfacs-Marrow-Granulocytes-24m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLNA HK3 ACTN1 ARAP3 IL1B PLK3 LILRB4

4.00e-061691707f38b52972a6c492ce2fd520a26bb3fc8db23bf85
ToppCellfacs-Liver-Non-hepatocytes-3m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HK3 WASF3 KSR2 ACTN1 DMPK LILRA5 LILRB4

4.00e-06169170744d841fd997a6f26104f16cd00223ecce8352f43
ToppCellfacs-Marrow-Granulocytes-24m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLNA HK3 ACTN1 ARAP3 IL1B PLK3 LILRB4

4.00e-0616917075320da1d61806b53e0bd96bbdfdb8fd69246681b
ToppCell10x5'-GI_small-bowel-Myeloid_Monocytic|GI_small-bowel / Manually curated celltypes from each tissue

SEMA6B NLRP12 LILRA2 HK3 BCAT1 IL1B LILRA5

4.33e-061711707098a7fd387357c0d4e1a6169af4d24ef95b30018
ToppCell10x5'-lymph-node_spleen-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|lymph-node_spleen / Manually curated celltypes from each tissue

NLRP12 HK3 BUB1B WDFY3 ESPL1 LILRA5 LILRB4

4.67e-061731707783b8fa08b9d8f597f251793eae164151662f1f9
ToppCell5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

FLNA HK3 SLCO2B1 RNF213 ARHGEF10L IQSEC1 ZFYVE26

4.85e-061741707d5c22b43531414951666ee7542a66ed9380e2d14
ToppCell10x5'-GI_small-bowel-Myeloid_Monocytic-Classical_monocytes|GI_small-bowel / Manually curated celltypes from each tissue

SEMA6B NLRP12 LILRA2 HK3 BCAT1 IL1B LILRA5

4.85e-06174170705d54a36772f096047521e16a89cc42ae48d2a1d
ToppCellfacs-Liver-Liver_non-hepato/SCs-18m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NRN1L HK3 ACTN1 DMPK IL1B LILRA5 LILRB4

4.85e-061741707dc4298c1d9359f7e37454e9451f889017227d5cf
ToppCellfacs-Heart-RV-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

EPPK1 DSC3 DGKG ACTN1 KLHL30 CSPG4 ASB2

5.04e-061751707d8e385320f554d974538b7cdc4f8e4767f1455f2
ToppCellfacs-Heart-RV-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

EPPK1 DSC3 DGKG ACTN1 KLHL30 CSPG4 ASB2

5.04e-061751707cf15465855602ba135752c18755e3e058dbd42ec
ToppCellStriatum-Macroglia-POLYDENDROCYTE-P1-P1_1|Striatum / BrainAtlas - Mouse McCarroll V32

ERBB3 OPN4 MAB21L4 SSPOP BTBD16 PLK3

5.60e-061161706c19974992b315fb873664fe3f5077ff8e907e30c
ToppCell5'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

FLNA ERC1 ACTN1 SSPOP CNNM1 ARAP3 ASB2

6.51e-061821707dfde2d9950f445c6c936ac828f7210de87bb45ec
ToppCell5'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

FLNA ERC1 ACTN1 SSPOP CNNM1 ARAP3 ASB2

6.51e-06182170752274af3136d4fd4a495f5882618444661421f0f
ToppCelldroplet-Lung-immune-endo-depleted-3m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TRIM46 NSD2 SLCO2B1 ACTN1 CSPG4 BUB1B CARD11

6.75e-06183170742dc31d587fbb9724b2f0be5ee8ed77233f67b86
ToppCell5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

FLNA BCAT1 LILRB1 HIVEP3 IL1B PLK3 LILRB4

7.00e-061841707857ca1fc4de07b300839b22924211dc624453841
ToppCellwk_08-11-Hematologic-Myeloid-APOE+_Mac2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

LILRA2 HK3 SLCO2B1 LILRB1 IL1B LILRA5 LILRB4

7.25e-0618517078f843badc0e26cb7300c83db56c7974beb90fcf3
ToppCell3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|lymph-node_spleen / Manually curated celltypes from each tissue

SEMA6B LILRA2 ARAP3 NOC4L ZFYVE26 LILRA5 YIPF3

7.78e-0618717073c10b8501226c69d71bcd99dc1c064a3c2154f87
ToppCell10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_naive-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

SEMA6B NLRP12 LILRA2 HK3 BCAT1 ACTN1 LILRA5

7.78e-0618717073b1439018e265a61d9599e307a202e3c2f60ed32
ToppCell10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_naive|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

SEMA6B NLRP12 LILRA2 HK3 BCAT1 ACTN1 LILRA5

7.78e-061871707e99bc27d212c74da37770297122a4b30445ccd0d
ToppCell10x_5'_v1-Non-neoplastic-Myeloid-Mono|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

SEMA6B NLRP12 LILRA2 HK3 BCAT1 ACTN1 LILRA5

8.05e-061881707fbf176b48b89c234e4e1e64739afc836bed78a96
ToppCellMacrophages-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id

FLNA SLCO2B1 ACTN1 GMIP ARHGEF10L CSPG4 IQSEC1

8.33e-061891707c05b4b565c0ce56dbb45fc9503654a2ec1a7e1e9
ToppCelldroplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLNA DGKG ACTN1 FAT2 CSPG4 ASB2 DMPK

8.93e-06191170760bc1f3efa7bbad5cb7944fe5e049ea79cd1745a
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

LILRA2 SLCO2B1 RNF213 ELL3 FAT2 KLHL30 LILRB4

9.23e-061921707935a4a36881a9fa4daa02cba96af07f6686ed8d6
ToppCell18-Distal-Epithelial-Secretory_progenitor|Distal / Age, Tissue, Lineage and Cell class

CYP2A6 CYP2A7 ERBB3 CYP2A13 IGFALS HES4 ATP1A1

9.23e-0619217079fae988ecd2ef1231bfd42a678a4903517694cbe
ToppCell3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

FLNA HK3 SLCO2B1 LILRB1 IQSEC1 ZFYVE26 LILRB4

9.55e-06193170750c2832de75b6469f649355c6b9a75e910d32db3
ToppCellwk_20-22-Hematologic-Myeloid-DC3|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

LILRA2 HK3 LILRB1 ARHGEF10L IL1B LILRA5 LILRB4

9.55e-06193170712d1e7ed0bcd1259d6dc8ae962aad69586e5d26b
ToppCell5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-Monocytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

NLRP12 LILRA2 HK3 LILRB1 IL1B LILRA5 LILRB4

9.55e-061931707c0509798ce06da0ec725c0c7b5cc195455f2c29f
ToppCell390C-Myeloid-Monocyte-CD14+_Monocyte|390C / Donor, Lineage, Cell class and subclass (all cells)

SEMA6B LILRA2 HK3 LILRB1 IL1B LILRA5 LILRB4

9.55e-061931707a50ee6110ea272d9d9f41d48bb5d43711cc00a32
ToppCelldroplet-Pancreas-Endocrine-21m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CAD KIF12 APLP1 IGFALS SF3B1 PRSS53 WDR6

9.88e-0619417073a3ecedcdc7691cf21775818b598208fcb980c29
ToppCelldroplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CAD KIF12 APLP1 IGFALS PRSS53 WDR6 ATP1A1

9.88e-0619417070b023de48ed8a550d169bbe954881eb04bf4f981
ToppCell21-Trachea-Immune-Hematopoietic,_Macrophage|Trachea / Age, Tissue, Lineage and Cell class

LILRA2 HK3 SLCO2B1 LILRB1 IL1B LILRA5 LILRB4

9.88e-0619417073c4ac5f91b10802990b84db3406f5e71f8ee8b74
ToppCellNS-critical-d_07-13-Myeloid-Non-resident_Macrophage|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

FLNA HK3 SLCO2B1 BCAT1 LILRB1 IL1B LILRB4

1.02e-051951707ee8743d39996bb756f50db32748e8a902d3294b8
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)

HK3 LILRB1 ARHGEF40 HES4 WDFY3 LILRA5 LILRB4

1.02e-0519517073a30479857fc2805df92655c9599389559b1995d
ToppCellmild_COVID-19_(asymptomatic)-Non-classical_Monocyte|World / disease group, cell group and cell class (v2)

LILRA2 LILRB1 HIVEP3 HES4 ASB2 LILRA5 LILRB4

1.02e-051951707eb809331557f8c40de45b1208cbc49b621930a4b
ToppCelldroplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

VPS13C KIF21A KIF12 APLP1 PRSS53 DDX3Y MAPK8IP2

1.02e-0519517073e519cffa6144a62b06124642a14c9ff39b76554
ToppCellPericytes|World / shred by cell class for parenchyma

FLNA DGKG ACTN1 CSPG4 HES4 ASB2 DMPK

1.06e-0519617078e7ecbe77d312a7fc6aadd8fd52c13dd1834cc7e
ToppCell(5)_Fibroblasts-(5)_Fibroblast-K_(Pericytes)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)

FLNA DGKG ACTN1 CSPG4 HES4 ASB2 DMPK

1.06e-051961707541b1fcf509e362f6f48720046cb5378aaf7c591
ToppCellwk_15-18-Hematologic-Myeloid-Neutrophil|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

TRPM4 NLRP12 LILRA2 HK3 LILRB1 IL1B LILRA5

1.06e-05196170736c01e0feea33448222010c21442b9fac671bd7d
ToppCell3'_v3-GI_small-bowel-Myeloid_Monocytic|GI_small-bowel / Manually curated celltypes from each tissue

NLRP12 LILRA2 HK3 ACTN1 IL1B LILRA5 LILRB4

1.09e-051971707dcf0009057576a7db9065e644a3919d6de2ac8e6
ToppCell5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LILRA2 HK3 LILRB1 ADGRE5 IL1B LILRA5 LILRB4

1.13e-0519817077015b9f5ead65937e056d746340d44d0655d6a3e
ToppCellmedial-Hematologic-Intermediate_Monocyte|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

LILRA2 BCAT1 LILRB1 MAP3K1 IL1B LILRA5 LILRB4

1.13e-051981707dbd7869483c5a67944cb94ced0ee2c7b999adc2e
ToppCellmedial-Hematologic-Intermediate_Monocyte-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

LILRA2 BCAT1 LILRB1 MAP3K1 IL1B LILRA5 LILRB4

1.13e-0519817078f64bb5cd8c3e2d5ef651821b0d59f67d1ca1a12
ToppCellmedial-2-Hematologic-Intermediate_Monocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

LILRA2 BCAT1 LILRB1 MAP3K1 IL1B LILRA5 LILRB4

1.13e-051981707432a26ace5b486695c9a933c0d44b73305b01ded
ToppCellTracheal-10x5prime-Immune_Myeloid-Monocytic-Monocyte_CD14|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

NLRP12 LILRA2 HK3 LILRB1 IL1B LILRA5 LILRB4

1.13e-0519817074ba72ba1f0cebc93053aae72d763c33e155b6fa4
ToppCell5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LILRA2 HK3 LILRB1 ADGRE5 IL1B LILRA5 LILRB4

1.13e-0519817076edf6c547e8a3aa2b23df4662bf59ed38caa9e5e
ToppCellNS-moderate-d_16-33-Myeloid-Non-resident_Macrophage|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

SEMA6B FLNA HK3 SLCO2B1 LILRB1 LILRA5 LILRB4

1.13e-05198170711a7a553de6786c1e8288251ba0d5c898505c158
ToppCellImmune-monocyte|World / Lineage, Cell type, age group and donor

NLRP12 HK3 NLRP1 LILRB1 MAP3K1 SH3TC1 LILRA5

1.13e-051981707d3622da252fd580f1dc5c7478a8e23df5ec083cf
ToppCell10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_granulocytic|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

LILRA2 ACTN1 ARHGEF40 WDFY3 IL1B LILRA5 PLK3

1.17e-051991707119807ea333d1dc7743c6b9f03a2c63e09e19541
ToppCell10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

LILRA2 ACTN1 ARHGEF40 WDFY3 IL1B LILRA5 PLK3

1.17e-051991707691e04871cd6cac0ea5fca1b7fd6421df9315db6
ToppCelldistal-2-Hematologic-Intermediate_Monocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

LILRA2 BCAT1 LILRB1 SH3TC1 IL1B LILRA5 LILRB4

1.17e-0519917075e209df67cfe8ac7437cc363f1c5c3166bfae1af
ToppCellPSB-critical-LOC-Myeloid-Macrophage|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

FLNA HK3 SLCO2B1 BCAT1 LILRB1 IL1B LILRB4

1.17e-051991707eada9bcac5c113561b806bb800cd53c6bb78e16a
ToppCellVE-granulo2|VE / Condition, Cell_class and T cell subcluster

LILRA2 LILRB1 ARHGEF10L HES4 IL1B LILRA5 LILRB4

1.17e-05199170705b47fdc01eccee0eaf4c781eeff93c47fe0533e
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

SEMA6B HK3 ACTN1 LILRB1 IL1B LILRA5 LILRB4

1.17e-051991707d3f77acb36ac7c56a47ca98b695f46ae5b9ecd12
ToppCellCOVID-19-Myeloid-MoAM3,_VCAN|COVID-19 / Condition, Lineage and Cell class

SEMA6B FLNA LILRA2 HK3 SLCO2B1 ACTN1 LILRB1

1.17e-051991707aba0b833e44fe42625fac91466f6ebaa8e786d3b
ToppCellSmart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

FLNA ACTN1 MAP3K6 FBXL6 PRSS53 FSCN2 DDX41

1.17e-05199170785bb28369e0568b7b3bda095722102fc793f60ef
ToppCellTracheal-10x3prime_v2-Stromal-Myofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

FLNA DGKG ACTN1 KLHL30 CSPG4 ASB2 DMPK

1.17e-051991707534dcfe8b65ad92bb8d749d1c7036ad4807e09cd
ToppCellPBMC-Control-cDC_0|Control / Compartment, Disease Groups and Clusters

FLNA NLRP12 HK3 NLRP1 LILRB1 ARHGEF10L LILRA5

1.17e-051991707ebf03979ef56e978d72db475bb635b43b9cbe402
ToppCellCOVID-19-lung|COVID-19 / Disease (COVID-19 only), tissue and cell type

FLNA PDE3B ABCA3 SLCO2B1 RNF213 ADGRE5 PARP12

1.17e-051991707155b03b859157013e9142e9248551369127d9204
ToppCellVE-granulo2-|VE / Condition, Cell_class and T cell subcluster

LILRA2 LILRB1 ARHGEF10L HES4 IL1B LILRA5 LILRB4

1.17e-051991707455e92047201ddd0c29a437a838e5fa135de7995
ToppCellTransverse-(4)_Monocyte|Transverse / shred on region, Cell_type, and subtype

LILRA2 HK3 BCAT1 ACTN1 IL1B LILRA5 LILRB4

1.20e-05200170785714e8da539366b5bce071dfea8f8055de527bc
ToppCellTransverse-Monocyte-Monocyte|Transverse / Region, Cell class and subclass

LILRA2 HK3 BCAT1 ACTN1 IL1B LILRA5 LILRB4

1.20e-05200170796ecfab57e998134e164b4a62881ef6f2612bd8d
ToppCellParenchymal-NucSeq-Immune_Myeloid-Monocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

LILRA2 HK3 LILRB1 MAP3K1 IQSEC1 LILRA5 LILRB4

1.20e-052001707fd72fe6565e2f4885481991492d58c323ab1ad40
ToppCellTracheal-10x5prime-Immune_Myeloid|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

LILRA2 HK3 SLCO2B1 LILRB1 IL1B LILRA5 LILRB4

1.20e-052001707fc6aebc20ecaa67606154540a691242dc0aea867
ToppCellLPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

FLNA SLC10A4 DGKG ACTN1 CSPG4 HES4 ASB2

1.20e-052001707b5b5a32925f225610fe25a021a742d6397162863
ToppCellTransverse-Monocyte|Transverse / Region, Cell class and subclass

LILRA2 HK3 BCAT1 ACTN1 IL1B LILRA5 LILRB4

1.20e-052001707d70aeb57b98496474b97906505576640fdbdf34c
ToppCellBronchial-10x5prime-Immune_Myeloid-Monocytic-Monocyte_CD16|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

LILRA2 HK3 LILRB1 MAP3K1 HES4 IL1B LILRA5

1.20e-052001707d39bf03817b76c9dfcbcd868341b51bb8601ea9b
ToppCellLPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

SLC10A4 DGKG ACTN1 CSPG4 HES4 MDGA1 NR1H4

1.20e-052001707d2fcd3bd7c3223875f027eeb48ff621192a5f242
ToppCellmLN-Macrophage|mLN / Region, Cell class and subclass

HK3 SLCO2B1 BCAT1 WDFY3 IL1B LILRA5 LILRB4

1.20e-05200170768d709afd226241e002dae6d6820bccd1cfd87a1
ToppCellmLN-(6)_Macrophage-(61)_LYVE1_Macrophage|mLN / shred on region, Cell_type, and subtype

HK3 SLCO2B1 BCAT1 WDFY3 IL1B LILRA5 LILRB4

1.20e-052001707a20f5ec61d492d8a2adf695ec304b5d57296aa8f
ToppCellmLN-Macrophage-LYVE1_Macrophage|mLN / Region, Cell class and subclass

HK3 SLCO2B1 BCAT1 WDFY3 IL1B LILRA5 LILRB4

1.20e-05200170789cf739a3c2f5d30e547404f2f2ec6500cd1d65d
ToppCellmLN-(6)_Macrophage|mLN / shred on region, Cell_type, and subtype

HK3 SLCO2B1 BCAT1 WDFY3 IL1B LILRA5 LILRB4

1.20e-0520017076dcba82a7d322102bae205543086e84c7655b3e0
ToppCellBronchial-10x5prime-Immune_Myeloid-Monocytic-Monocyte_CD14|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

NLRP12 LILRA2 HK3 LILRB1 IL1B LILRA5 LILRB4

1.20e-0520017071aa4197f1c7c099313dc2e1f8b1153252add7a33
ToppCellTransverse-(4)_Monocyte-(40)_Monocyte|Transverse / shred on region, Cell_type, and subtype

LILRA2 HK3 BCAT1 ACTN1 IL1B LILRA5 LILRB4

1.20e-0520017070187a4b1d2c3c89b7769d632e6d88190a06b093e
ToppCellLPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_only / Treatment groups by lineage, cell group, cell type

SLC10A4 DGKG ACTN1 ARHGEF40 CSPG4 HES4 SUFU

1.20e-05200170769edc375d85689300d1dbc1217fedc40063ecdcb
ToppCellBronchus_Control_(B.)-Immune-TX-MoAM-1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type

SEMA6B FLNA BCAT1 LILRB1 IL1B LILRA5 LILRB4

1.20e-052001707fe7f8b04067b6680b69c8523f0fa514ef97207e2
ToppCellControl_saline-Mesenchymal_myocytic-Pericyte-Pericyte_3|Control_saline / Treatment groups by lineage, cell group, cell type

FLNA DGKG ACTN1 ASB10 CSPG4 HES4 ASB2

1.20e-052001707b0866b497aa71d06cef25f9a335fa584e95fa7e0
ToppCellsevere-CD163+_Monocytes_(Sample_ID1_d7)|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

NLRP12 LILRA2 HK3 LILRB1 WDFY3 LILRA5 LILRB4

1.20e-0520017074943fe826d5fcc3dfeb8b99a7415848f3fecc994
ToppCellParenchymal-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD14|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

SEMA6B NLRP12 LILRB1 SH3TC1 IQSEC1 IL1B LILRA5

1.20e-052001707b4277b6faa69f20974696c7c422311f5c89e3663
ToppCellfacs-Marrow-T-cells-24m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLNA ACTN1 ARAP3 IL1B PLK3 LILRB4

2.52e-051511706ced4f7ee377a23a804ae6fde624e8b55b79f1fd8
Drug2'-methoxyacetophenone

CYP2A6 CYP2A7 CYP2A13

3.81e-0731663CID000068481
Diseaseleukocyte immunoglobulin-like receptor subfamily B member 1 measurement

LILRA2 LILRB1 C6orf15 LILRB4

1.11e-06151614EFO_0008208
DiseaseMalignant neoplasm of breast

FLNA ERBB3 ABCA3 HK3 DSC3 NSD2 SLCO2B1 RPS6KB2 OBSCN DGKG MAP3K6 MAP3K1 DDX3X EPG5 ARAP3 UMPS ZFYVE26 IL1B MED12 DOP1A

1.78e-06107416120C0006142
Diseasechildhood medulloblastoma (implicated_via_orthology)

DDX3X DDX3Y

2.96e-0521612DOID:3869 (implicated_via_orthology)
DiseaseCongenital hypoplastic anemia

CAD UMPS

2.96e-0521612C0949116
Diseaseorotic aciduria (implicated_via_orthology)

CAD UMPS

2.96e-0521612DOID:0050833 (implicated_via_orthology)
DiseaseFG syndrome (is_implicated_in)

FLNA MED12

8.84e-0531612DOID:14711 (is_implicated_in)
DiseaseFG SYNDROME 4 (disorder)

FLNA MED12

8.84e-0531612C1845546
DiseaseFG SYNDROME 2

FLNA MED12

8.84e-0531612C1845902
DiseaseFG SYNDROME 3

FLNA MED12

8.84e-0531612C1845567
DiseaseFG syndrome

FLNA MED12

8.84e-0531612C0220769
DiseaseFG syndrome

FLNA MED12

1.76e-0441612cv:C0220769
DiseaseSertoli cell-only syndrome (implicated_via_orthology)

DDX3X DDX3Y

1.76e-0441612DOID:0050457 (implicated_via_orthology)
DiseaseAcute Erythroblastic Leukemia

CAD UMPS

1.76e-0441612C0023440
DiseaseMalignant Cystosarcoma Phyllodes

FLNA MED12

2.93e-0451612C0600066
DiseasePhyllodes Tumor

FLNA MED12

2.93e-0451612C0010701
DiseaseMacrothrombocytopenia

FLNA ACTN1

2.93e-0451612C2751260
DiseaseDwarfism

WDR4 IGFALS IQSEC1

3.36e-04251613C0013336
Diseaseglucose metabolism disease (implicated_via_orthology)

HK3 RPS6KB2 DGKG

4.72e-04281613DOID:4194 (implicated_via_orthology)
Diseasetoll/interleukin-1 receptor domain-containing adapter protein measurement

NLRP12 RPUSD4

6.10e-0471612EFO_0802134
DiseaseHereditary spherocytosis

CAD UMPS

8.11e-0481612C0037889
Diseasesialic acid-binding Ig-like lectin 12 measurement

NLRP12 UMPS

8.11e-0481612EFO_0802066
DiseaseDermatitis, Atopic

CARD11 IL1B IFNL3

9.97e-04361613C0011615
DiseaseEczema, Infantile

CARD11 IL1B IFNL3

9.97e-04361613C0086196
DiseaseGout

SLC2A9 IL1B

1.04e-0391612C0018099
DiseaseShort Stature, CTCAE

IGFALS IQSEC1

1.29e-03101612C2919142
DiseaseAnemia, Sickle Cell

CAD UMPS

1.29e-03101612C0002895
DiseaseShort stature

IGFALS IQSEC1

1.29e-03101612C0349588
Diseasewhite matter microstructure measurement

EPPK1 TRIM65 STN1 CARD11 WDFY3 ASB2 SUFU SLC27A3

1.41e-033901618EFO_0005674
Diseaseleukocyte immunoglobulin-like receptor subfamily B member 2 measurement

LILRB1 LILRA5

1.58e-03111612EFO_0008209
DiseaseColorectal Carcinoma

CYP2A6 ABCA3 CAD HK3 OBSCN ARHGEF10L HIVEP3 ARAP3 SH3TC1 BUB1B UMPS

1.70e-0370216111C0009402
DiseaseSquamous cell carcinoma of esophagus

CYP2A6 FAT2 BUB1B LTA

1.85e-03951614C0279626
DiseaseCooley's anemia

CAD UMPS

1.88e-03121612C0002875
DiseaseThalassemia Intermedia

CAD UMPS

1.88e-03121612C0271979
Diseasenicotine metabolite ratio

CYP2A6 CYP2A7

1.88e-03121612EFO_0007794
DiseaseThalassemia Minor

CAD UMPS

1.88e-03121612C0085578
Diseasebeta Thalassemia

CAD UMPS

1.88e-03121612C0005283
Diseasetumor necrosis factor receptor superfamily member EDAR measurement

EDAR SUFU

1.88e-03121612EFO_0008310
Diseasepancreatic cancer (is_marker_for)

SLCO2B1 BUB1B ADGRE5 IL1B

2.31e-031011614DOID:1793 (is_marker_for)
DiseaseMammary Carcinoma, Human

FLNA ERBB3 DSC3 NSD2 RPS6KB2 MAP3K1 UMPS IL1B MED12

2.46e-035251619C4704874
DiseaseMammary Neoplasms, Human

FLNA ERBB3 DSC3 NSD2 RPS6KB2 MAP3K1 UMPS IL1B MED12

2.46e-035251619C1257931
DiseaseMammary Neoplasms

FLNA ERBB3 DSC3 NSD2 RPS6KB2 MAP3K1 UMPS IL1B MED12

2.52e-035271619C1458155
DiseaseHamman-Rich syndrome

ABCA3 STN1

2.58e-03141612C0085786
DiseaseBreast Carcinoma

FLNA ERBB3 DSC3 NSD2 RPS6KB2 MAP3K1 UMPS IL1B MED12

2.89e-035381619C0678222
DiseaseHepatitis C

CYP2A6 IFNL3

2.97e-03151612C0019196
DiseaseHemoglobin F Disease

CAD UMPS

2.97e-03151612C0019025
DiseaseFEV/FEC ratio

ERBB3 ABCA3 SLC2A9 ERC1 VPS13C KSR2 DGKG MAP3K1 HIVEP3 BTBD16 RPUSD4 CSPG4 LRRN2 MTCL1 SUFU

3.05e-03122816115EFO_0004713
DiseaseDyskeratosis Congenita

STN1 DKC1

3.38e-03161612C0265965
DiseaseAlzheimer's disease (implicated_via_orthology)

APLP1 HIVEP3 IL1B

3.76e-03571613DOID:10652 (implicated_via_orthology)
Diseasecystitis (biomarker_via_orthology)

LTA IL1B

4.27e-03181612DOID:1679 (biomarker_via_orthology)
Diseasenephrotic syndrome (is_marker_for)

IGFALS IL1B

4.27e-03181612DOID:1184 (is_marker_for)
Diseasenon-alcoholic fatty liver disease (is_implicated_in)

ADRB3 IL1B

4.27e-03181612DOID:0080208 (is_implicated_in)
Diseasecaffeine metabolite measurement

CYP2A6 CYP2A7

4.76e-03191612EFO_0007872
DiseaseMalignant Neoplasms

ERBB3 BIRC6 SF3B1 IL1B

5.39e-031281614C0006826

Protein segments in the cluster

PeptideGeneStartEntry
GDLSPRCLILRNRIH

BUB1B

881

O60566
LDHAHIVRLLGLCPG

ERBB3

766

P21860
VLQRVGCPGDHLFLL

EPG5

466

Q9HCE0
IHSANKCRLRLLLPG

ARHGEF10L

706

Q9HCE6
GPNSLHCLGSLRERL

ELL3

96

Q9HB65
GLGFCALIHRHRPEL

ACTN1

176

P12814
TCSPREHVLLGRARG

ARHGEF40

1051

Q8TER5
CHQLLGPGLLRLGRL

ARAP3

791

Q8WWN8
ITPCADGIHLLVGLR

BIRC6

736

Q9NR09
DGIHLLVGLRTCPVE

BIRC6

741

Q9NR09
LPGVTRRCILDLAHQ

BCAT1

286

P54687
GTSRPLRGCLHAATL

CSPG4

161

Q6UVK1
FLRPGGDHDCVLVLL

DCTN1

596

Q14203
IHLGPRRVVVLCGHD

CYP2A6

71

P11509
RPLFLCLRLHGITKG

BTBD16

321

Q32M84
VISPLLVAIRHGCLR

ASB2

441

Q96Q27
ARTLRHLGLAGCKLP

CARMIL2

461

Q6F5E8
GHVELADLLLRRGAC

ASB10

226

Q8WXI3
LGPLAIIGTCAHLIR

GPR32

226

O75388
GQVGLRCRLVAGLLH

ADGRE5

606

P48960
VAGLCGRLTLHRDLR

APLP1

56

P51693
ARLRGIPERHIGACV

ABCA3

1481

Q99758
LHLEGSCLGRIRPHT

IGFALS

391

P35858
CRRTLHVRLQIGPGD

DOP1A

446

Q5JWR5
SLLCLLRHGADPEVR

ANKRD61

91

A6NGH8
HGSPNLRLLDLRGCA

FBXL6

381

Q8N531
RLLPLREHRALCTLG

ADRB3

281

P13945
SGLPVRNGRLHACEV

NPR1

931

P16066
HGLDGCASLLRDILR

CCDC14

106

Q49A88
PVHILREIGLRLSHC

DCAF16

86

Q9NXF7
VVRALRHAVPAGILC

ALG12

206

Q9BV10
RHAVPAGILCLGLTV

ALG12

211

Q9BV10
DGRIVLAAHRCGLRP

ANTKMT

86

Q9BQD7
TTLCHDRDPLILRGL

ERC1

1031

Q8IUD2
HSCLLRPRSLDAGIP

NFILZ

136

A0A5F9ZHS7
IQRCDLAAHLGLRAP

MTCL1

726

Q9Y4B5
PQHFACLLGRLTELR

NR1H4

441

Q96RI1
SAVVPRGGHVTLLCR

KIR2DL5A

36

Q8N109
TLLVGGRELPCHRGL

KLHL30

36

Q0D2K2
GRELPCHRGLLALSS

KLHL30

41

Q0D2K2
TVLICLGLSLGPRTH

LILRA2

6

Q8N149
AHVRRPVGALLAALC

SLC10A4

131

Q96EP9
PGGCLQTLLHRAIDE

ANKFY1

721

Q9P2R3
LLLLALIPFHCRGQG

MDGA1

6

Q8NFP4
RDLERGCHLLVATPG

DDX3X

311

O00571
LELCHLGVPREGAGL

MAB21L4

106

Q08AI8
LCPLDGGIQLRISDH

IL1B

41

P01584
LLCLGLSLGPRTHVQ

LILRA5

26

A6NI73
QIISHNLRPGLCLGR

MDN1

1556

Q9NU22
AEGCRPARLLGLVHD

NEUROG2

71

Q9H2A3
TALLCLGLSLGPRTH

LILRB4

6

Q8NHJ6
ETLLILCGHRRLPAR

GMIP

531

Q9P107
LALGHCISLLLDPQR

KIF12

291

Q96FN5
CHRALGDRPGLIAIL

LRRN2

621

O75325
PERILDRCSSILLHG

ATP1A1

511

P05023
CRIAGRQDPGTELLH

HINT3

51

Q9NQE9
GLGCVLSLPHRRLVC

IQSEC1

741

Q6DN90
CHLLIIHRGDPARLV

KSR2

456

Q6VAB6
GSPELCLLSLVHLAR

EDAR

296

Q9UNE0
LELVSLRRCAGLGHD

MAPK8IP2

521

Q13387
LGELVPRLCELIRSG

ECPAS

1356

Q5VYK3
SAVVPRGGHVTLLCR

KIR2DL5B

36

Q8NHK3
LGRNHVEELLRCLGA

MAP3K6

1031

O95382
NCRGLRPERHLLLGG

FAT2

3881

Q9NYQ8
LSCVGLLLTLAHPLR

PDE3B

201

Q13370
DVGVRLLCEGLRHPA

NLRP1

936

Q9C000
HLACLGLSRRPEGRF

NSD2

691

O96028
LRFPETRLGRLLLCH

KCNS2

36

Q9ULS6
GACLGSALVTLRHRL

MEGF8

2796

Q7Z7M0
PLCIRALLNLHTDVG

NEK8

256

Q86SG6
EPGARLTCRILLHLF

MED12

1166

Q93074
LRLAVDGRLSLCFHP

GNL1

506

P36915
RVAEVRGPAHCLLLG

QPRT

86

Q15274
RGPAHCLLLGERVAL

QPRT

91

Q15274
GHRPRTCILLRGDQT

PRR25

36

Q96S07
CGRPASGRLLSLHLE

PRR25

186

Q96S07
RTLPLCVIGGDHKLL

NUP37

306

Q8NFH4
LIICPSRELARQTHG

DDX41

261

Q9UJV9
GHILPLRRFLENCLD

FOXRED2

576

Q8IWF2
GELVRLVLAHLARCG

HK3

316

P52790
GDLVHLEGPLRLSCA

IGHV8-51-1

26

P0DTE2
ILLDRCGHIRLADFG

DMPK

201

Q09013
LCDVLLIAGHLRIPA

KLHL4

181

Q9C0H6
VLAASPLRLCRAHQG

PARP12

66

Q9H0J9
LSPRHLVLILELCSG

OBSCN

7736

Q5VST9
PCLGVLLGVSRRHSR

OPN4

366

Q9UHM6
LVCLHLPGLFARSIG

C6orf15

16

Q6UXA7
RRQPGLLHLQSCGDL

FAM189A2

401

Q15884
TLCDGGELRDHILLP

DGKG

381

P49619
ACPRHLGSLLELAEL

ESPL1

66

Q14674
IHLGPRRVVVLCGHD

CYP2A13

71

Q16696
RGLLVGILRCAHLAA

DOC2A

266

Q14183
PRRSVRGAVCLHLLL

DSC3

6

Q14574
LLHELPDRRSCLAAG

FITM1

161

A5D6W6
TRHLCDGAIGRQLPA

DCDC2B

111

A2VCK2
LLEACPRLRALGLHL

FBXL8

186

Q96CD0
DRLIRIFCLHPGLLV

FBXO15

286

Q8NCQ5
PCLLKRLRNGHVGIS

FLNA

1996

P21333
IHLGPRRVVVLCGHD

CYP2A7

71

P20853
HLLRGAPQEVTLLLC

FRMPD2B

161

Q6IN97
LGPLAIIGTCAHLIR

GPR32P1

226

Q8NGA4
RLRGALPDARGCHIA

IFNL3

26

Q8IZI9
ARGGASLLLLDCRPH

DUSP7

66

Q16829
GGNLLILRISHCPNI

FBXO41

656

Q8TF61
GHLAACLRQLGPSRR

HES4

141

Q9HCC6
LLRELHCPDRALCGG

FAM98C

86

Q17RN3
RALLECDHLRSGVPG

SLC2A9

31

Q9NRM0
ICSREHIRKSLGLPG

ENDOV

241

Q8N8Q3
ALGGVVLRCDTRLHP

FCRLB

211

Q6BAA4
LERGCHLLVATPGRL

DDX3Y

311

O15523
IRTLCVHLGLLLGVG

DKC1

226

O60832
VCIRVLGDLHLLPLD

DHDDS

116

Q86SQ9
GLRKLRNLLPEHGCL

SCAP

156

Q12770
LLGRPGELCAQHFTL

NOC4L

501

Q9BVI4
LREGHQLLLLEGCIR

CARD11

706

Q9BXL7
LLLRAHPGVLSERCT

DIPK1C

41

Q0P6D2
GRSPNHIVVLCRGRA

CROT

186

Q9UKG9
RPILVLRGLDGFVCH

FSCN2

381

O14926
HLSPGLRDVALRCLE

MAP3K1

1476

Q13233
LHTLCGAPVHVRERG

NRN1L

111

Q496H8
CGLPHGESALSRLLR

PLD6

71

Q8N2A8
HLTIRLALGGCTNRP

MRPS16

16

Q9Y3D3
LRVHLSFGLDCPILG

RPUSD4

271

Q96CM3
LPVLCSGTAGHLLGR

MRPS5

11

P82675
VFHALSRCLGGLLRP

SZT2

121

Q5T011
HILACARLSIRPGLS

STN1

326

Q9H668
LPLLLAADRLLTGCH

TRIM46

561

Q7Z4K8
RLRRVHVCGGSLLSP

TPSG1

56

Q9NRR2
HRTECPLGGLLLTLG

SMYD4

331

Q8IYR2
ESPVRILNLRCLGGH

SSPOP

5111

A2VEC9
ILNLRCLGGHTEPVV

SSPOP

5116

A2VEC9
HLTRCGVLGALRELR

THEM6

81

Q8WUY1
TQRCRLGPAALHALG

SPATA5L1

26

Q9BVQ7
RIGPHCFELLRVLGK

RPS6KB2

61

Q9UBS0
TVLICLGLSLGPRTH

LILRB1

6

Q8NHL6
GVHLPQAAACRLGLL

EPPK1

1371

P58107
LPLGECGRDFTHVLL

SH3TC1

936

Q8TE82
LGLCHSRIFDVLLPR

SPATA3

126

Q8NHX4
HGIGPVCDLRFRSII

SEC23IP

451

Q9Y6Y8
HRLVLRLLGCISAGV

SLC39A2

41

Q9NP94
LLRLRPHLDGCRGDI

CHPF2

236

Q9P2E5
RGRGTHLLCTLLLGQ

CNNM1

276

Q9NRU3
CGIQLLHIGRPLAAF

CNOT10

361

Q9H9A5
LGALRSRLGHAPCVA

RECQL5

176

O94762
VTLLGPRACSRLHAA

PRSS53

436

Q2L4Q9
LGRFPAHILDCLSGI

RNF213

781

Q63HN8
LASHLRQLGCSPDLR

PLK3

616

Q9H4B4
RGCHARPGTDLAHLL

SEMA6B

861

Q9H3T3
RLFLPRVCGTTLHLL

LTA

6

P01374
RGHRAPVSALCINEL

WDFY3

3166

Q8IZQ1
HLDTPVVRSAGGRLC

TAS1R1

591

Q7RTX1
LLLCRGGGHPLDLLS

SPHK2

306

Q9NRA0
LRRGPLLHCLRSCGA

SLC27A3

201

Q5K4L6
LVKRLHLGPVGCGAL

SLCO2B1

431

O94956
HPVLLSGCRGGILKV

KIF21A

1596

Q7Z4S6
GCAILPHLRSLVEII

SF3B1

676

O75533
LPRRVGCQLLHVAGR

USP35

56

Q9P2H5
RHLCRGALPEGITSE

WASF3

11

Q9UPY6
IPLCLRGRLLHGRHF

SUFU

381

Q9UMX1
LTLCPLGRELAPRAH

HIVEP3

2036

Q5T1R4
EVGLPLHRGCLLIAE

UMPS

356

P11172
GTLLCACGHRLREGL

KRT10-AS1

81

Q8N816
ACGHRLREGLLLPCL

KRT10-AS1

86

Q8N816
LAGEQALPLCGHRDR

SCART1

711

Q4G0T1
TLECGLGHRTVPLLL

VPS13C

2286

Q709C8
LREGICSRLPGHYLR

MRPL28

16

Q13084
LYRALGGCTRPHVIL

WDR6

681

Q9NNW5
PLAKILCHRGGVRAV

WDR46

351

O15213
RHQILRPGLRVLDCG

MRM2

66

Q9UI43
RPVFGICLGHQLLAL

CAD

246

P27708
LRTLELLLICAGHPQ

TNPO3

321

Q9Y5L0
PTQRLLLCGTLAALH

YIPF3

271

Q9GZM5
RLLRHVALGLFCCGI

TMEM221

116

A6NGB7
GFRRVLCVGTPRLHE

ZCCHC4

191

Q9H5U6
VLEPHGCGRLELGHL

WDR4

131

P57081
LLEGRTLTLCHQPGA

TRIM65

491

Q6PJ69
GSPLREERLLSCLLH

ZFYVE26

251

Q68DK2
CRLTPGLYHLGRTVL

TRPM4

881

Q8TD43
GVILSRSPGLVLCHG

TYSND1

36

Q2T9J0
GHQFRLRLAPILCDG

ZW10

556

O43264
SLHGRRLLRVGGACP

nan

16

Q6ZSA8
GSRGVKLLCQGLRHP

NLRP12

726

P59046
DLGLRLLCQGLRHPV

NLRP12

841

P59046
GDTGVRLLCKRLSHP

NLRP12

1011

P59046